Tafluprost Production Cost Reports

The report provides a detailed analysis essential for establishing a tafluprost production plant. It encompasses all critical aspects necessary for tafluprost production, including the cost of tafluprost production, tafluprost plant cost, tafluprost production costs, and the overall tafluprost production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a tafluprost production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Tafluprost is a medication that is used as an ophthalmic solution to treat glaucoma and ocular hypertension. It lowers intraocular pressure through enhanced uveoscleral outflow of aqueous humour. It is administered once daily, mainly in the evening, via preservative-free eye drops. It effectively prevents optic nerve damage and vision loss in patients with open-angle glaucoma, matching or exceeding the efficacy of similar drugs like latanoprost. It is used in combination therapies for better control in treatment-resistant cases, normal-tension glaucoma, or when switching from other prostaglandins like latanoprost for improved tolerability. Its common side effects include eye redness, itching, blurred vision, eyelash growth, and potential darkening of the iris or eyelids.

The market for tafluprost is influenced by rising glaucoma prevalence and ageing populations. The innovations, like preservative-free formulations and generics, improving affordability in emerging markets, contribute to its market growth. Its utilisation in combination therapies increases its efficiency for several other problems, which expands its applications. The increased eye health awareness, along with high R&D costs and regulatory problems, boosts its market. The industrial tafluprost procurement is influenced by supply chain dependencies on manufacturers, patent expirations enabling price drops, and quality variability in generics. Other factors, like side effects, competition from other prostaglandins, and treatment costs in developing regions, affect its sourcing strategies.

Raw Material for Tafluprost Production

According to the tafluprost production plant project report, the key raw materials used in the production of tafluprost include cyclopentadiene and alkenylboronic acid.

Production Process of Tafluprost

The extensive tafluprost production cost report consists of the following major industrial production process:

1. From cyclopentadiene: The production process of tafluprost involves several steps. The process starts with a key Rh-catalysed asymmetric Suzuki–Miyaura coupling using SEGPHOS ligand (L6) to form bicyclic alkenyl cyclopentene. This is followed by conversion to cyclic carbonate, then Pd-catalysed Tsuji–Trost allylation with diethyl malonate to give an intermediate. The hydrolysis and decarboxylation to acid, followed by iodolactonization and radical deiodination of the lactone, gives a hemiacetal. The final Z-selective Wittig olefination with (4-carboxybutyl)triphenylphosphonium bromide and esterification using isopropyl iodide and DBU, gives tafluprost as the final product.

Tafluprost is a fluorinated prostaglandin analogue with the molecular formula C25H34F2O5 and a molecular weight of 452.54 g/mol. It appears as a colourless to pale yellow viscous oil or waxy solid. It has a melting point around 87.5 degrees Celsius with low water solubility but good solubility in ethyl acetate and organic solvents, reflecting its formulation as a lipophilic ophthalmic solution. It has a complex structure including a cyclopentane ring, difluorinated side chain, and isopropyl ester, with an exact mass of 452.2374 Da. All these physical and chemical properties make it useful as an ophthalmic solution to treat glaucoma and ocular hypertension.